phase readout
saveNCT06585969: A Randomised Trial Comparing Trastuzumab Deruxtecan to CDK4/6 Inhibitors in Non-luminal A, ER-positive/HER2-low Metastatic Breast Cancer
WITHDRAWNupdated 1mo ago
community read0 votes
Sponsor: Danish Breast Cancer Cooperative Group. Phase: PHASE3. Conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, Luminal B, Her2 Enriched, Basal Like
view source ↗
comments(0)
5-min edit window · permanent after that